|
|
|
| Therapy for Latent Tuberculosis |
||
| Infection |
||
|
|
|
|
|
|
|
|
|
|
| • | Rationale |
||||||||
| – | Reduce
individual risk for developing |
||||||||
| active disease |
|||||||||
| – | Shrink pool of
infected persons at risk |
||||||||
| for
tuberculosis |
|||||||||